In silico design and evaluation of a novel therapeutic agent against the spike protein as a novel treatment strategy for COVID-19 treatment
Description
CONCLUSIONS: In silico studies can provide a good opportunity to study viral proteins and new drugs or compounds since they do not need direct exposure to infectious agents or equipped laboratories. The suggested therapeutic agent should be further
